Earnings Summary for Paragon 28 Inc

authorIntellectia.AI Updated: 1970-01-01
2
FNA.N
Illustration by Intellectia.AI

Earnings Summary for Paragon 28, Inc.

Paragon 28, Inc. Reports Financial Results for Q2 2024

Overview: Paragon 28, Inc. has announced its financial results for the fiscal quarter ending June 30, 2024.

Key Financial Metrics

Metric Q2 2024 Q1 2024 Q2 2023 Year-over-Year Change Quarter-over-Quarter Change
Revenue ($ millions) $61.0 $61.1 $51.0 20% -0.16%

Interpretation: The company showed a strong performance, with revenue increasing by 20% year-over-year from Q2 2023. However, the quarter-over-quarter change in revenue from Q1 2024 to Q2 2024 was a slight decline of -0.16%, indicating stable revenue levels.

Revenue Performance by Segment

Segment Q2 2024 Year-over-Year Change Comment
US Revenue ($ millions) $49.7 18% Driven by increased surgical volume, sales force expansion, and new product launches.
International Revenue ($ millions) $11.3 29% Growth driven by the UK, Australia, South Africa, and new Kuwaiti market launch.

Interpretation: Both US and international segments showed substantial growth, with international revenue growing by 29% year-over-year, largely due to strategic expansion efforts in new regions.

Stock Price Movement

As per the earnings release: - After the earnings event, the stock price increased by 5.19%.

In summary, Paragon 28, Inc. has seen strong year-over-year growth and maintained steady revenue levels quarter-over-quarter for Q2 2024. The company’s international growth and strategic product launches have been significant contributors to this success.